Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.

Sarcoma

Tabone-Eglinger S, Bahleda R, Côté JF, Terrier P, Vidaud D, Cayre A, Beauchet A, Théou-Anton N, Terrier-Lacombe MJ, Lemoine A, Penault-Llorca F, Le Cesne A, Emile JF.
PMID: 18769552
Sarcoma. 2008;2008:849156. doi: 10.1155/2008/849156.

Malignant peripheral nerve sheath tumours (MPNSTs) are highly malignant and resistant. Transformation might implicate up regulation of epidermal growth factor receptor (EGFR). Fifty-two MPNST samples were studied for EGFR, Ki-67, p53, and survivin expression by immunohistochemistry and for EGFR...

Cite
Tabone-Eglinger S, Bahleda R, Côté JF, et al. Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma. 2008;2008:849156doi: 10.1155/2008/849156.
Tabone-Eglinger, S., Bahleda, R., Côté, J. F., Terrier, P., Vidaud, D., Cayre, A., Beauchet, A., Théou-Anton, N., Terrier-Lacombe, M. J., Lemoine, A., Penault-Llorca, F., Le Cesne, A., & Emile, J. F. (2008). Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma, 2008849156. https://doi.org/10.1155/2008/849156
Tabone-Eglinger, Séverine, et al. "Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs." Sarcoma vol. 2008 (2008): 849156. doi: https://doi.org/10.1155/2008/849156
Tabone-Eglinger S, Bahleda R, Côté JF, Terrier P, Vidaud D, Cayre A, Beauchet A, Théou-Anton N, Terrier-Lacombe MJ, Lemoine A, Penault-Llorca F, Le Cesne A, Emile JF. Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma. 2008;2008:849156. doi: 10.1155/2008/849156. PMID: 18769552; PMCID: PMC2526168.
Copy Download .nbib Format: NLM
Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience.

Urologic oncology

Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP.
PMID: 21224114
Urol Oncol. 1995 Sep-Oct;1(5):175-83. doi: 10.1016/1078-1439(95)00062-3.

To assess the role of chemotherapy in the treatment of stage II nonseminomatous germ-cell tumors of the testis, the outcomes of 154 patients who were included in prospective trials and standard treatment programs at Institut Gustave Roussy between 1984...

Cite
Culine S, Theodore C, Terrier-Lacombe MJ, et al. Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience. Urol Oncol. 1995;1(5):175-83doi: 10.1016/1078-1439(95)00062-3.
Culine, S., Theodore, C., Terrier-Lacombe, M. J., & Droz, J. P. (1995). Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience. Urologic oncology, 1(5), 175-83. https://doi.org/10.1016/1078-1439(95)00062-3
Culine, S, et al. "Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience." Urologic oncology vol. 1,5 (1995): 175-83. doi: https://doi.org/10.1016/1078-1439(95)00062-3
Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP. Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience. Urol Oncol. 1995 Sep-Oct;1(5):175-83. doi: 10.1016/1078-1439(95)00062-3. PMID: 21224114.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries